NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Aavas Financiers Sees Robust Turnaround in Q4FY26, Enters FY27 on a Clean Slate

Aavas Financiers (Aavas) marked a pivotal year in FY26, characterized by significant leadership transitions. CVC Capital Partners entered as a promoter, and Mr. Manu Singh took over as MD & CEO, while Mr. Ripudaman Bandral was appointed as CBO. Initially, internal restructuring and industry headwinds impacted the company's performance in the first nine months of FY26. However, Q4FY26 witnessed a robust turnaround, with record quarterly disbursements of INR 23.5 billion, a 36% quarter-over-quarter (QoQ) increase. This turnaround was further reflected in a greater than 40 basis points (bps) QoQ net interest margin (NIM) expansion and a sharp 63bps QoQ improvement in 1+ Days Past Due (DPD), which moderated to 3.17%.

Key Performance Indicators in Q4FY26

QuarterDisbursements (INR billion)NIM (bps)1+ DPD
Q3FY2617.23.54
Q4FY2623.540bps (QoQ)3.17

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

With the transitory challenges largely behind, Aavas enters FY27 with a clean slate, positioning itself to achieve its medium-term targets of 20%+ asset under management (AUM) growth and mid-teen return on equity (RoE). The company's strong performance in Q4FY26 underscores its ability to navigate industry headwinds and capitalize on emerging opportunities.

Maintaining a BUY recommendation with an unchanged target price of INR 1,725, ICICI Securities values the stock at 2.3 times its estimated market value for March 2027.

Investor Takeaway

Maintain BUY with an unchanged TP of INR 1,725, valuing the stock at 2.3x Mar'27E.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.